Prognosis of patients with hepatocellular carcinoma and hypersplenism after surgery: A single-center experience from the people's Republic of China

OncoTargets and Therapy

Volumn 7, Issue , 2014, Pages 957-964

  Li, Cong ^a   Zhao, Hong ^a   Zhao, Jianjun ^a   Li, Zhiyu ^a   Huang, Zhen ^a   Zhang, Yefan ^a   Bi, Xinyu ^a   Cai, Jianqiang ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Disease free survival; Hepatectomy; Overall survival; Splenectomy

Indexed keywords

ANTICOAGULANT AGENT;

ABDOMINAL BLEEDING; ACUTE LIVER FAILURE; ADULT; AGE; ANTICOAGULANT THERAPY; ARTICLE; ASCITES; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CHILD PUGH SCORE; CHINA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERSPLENISM; LIVER CELL CARCINOMA; LIVER RESECTION; LUNG INFECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROVASCULAR INVASION; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; SMOKING; SPLEEN VEIN THROMBOSIS; SPLENECTOMY; TUMOR VOLUME; VEIN THROMBOSIS; WOUND INFECTION;

EID: 84902353136     PISSN: 11786930     EISSN: None     Source Type: Journal    
DOI: 10.2147/OTT.S64921     Document Type: Article

References (33)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371: 838-851.
3. Capussotti L, Ferrero A, Vigano L, Muratore A, Polastri R, Bouzari H. Portal hypertension: contraindication to liver surgery? World J Surg. 2006;30(6):992-999.
4. Stanca CM, Fiel MI, Aledort L, Cohen E, del Rio Martin J, Schiano TD. Factors associated with persistent thrombocytopenia after liver transplantation. Transplant Proc. 2010;42:1769-1773.
5. Ikegami T, Shimada M, Imura S. Recent role of splenectomy in chronic hepatic disorders. Hepatol Res. 2008;38:1159-1171.
6. Imura S, Shimada M, Utsunomiya T, et al. Impact of splenectomy in patients with liver cirrhosis: Results from 18 patients in a single center experience. Hepatol Res. 2010;40:894-900.
7. Oh JW, Ahn SM, Kim KS, Choi JS, Lee WJ, Kim BR. The role of splenectomy in patients with hepatocellular carcinoma and secondary hypersplenism. Yonsei Med J. 2003;44(6):1053-1058.
8. Sugawara Y, Yamamoto J, Shimada K, et al. Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg. 2000;190(4):446-450.
9. Henderson JM. Surgical treatment of portal hypertension. Baillieres Best Pract Res Clin Gastroenterol. 2000;14(6):911-925.
10. Fan ST, Lo CM, Liu CL, et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg. 1999;229(3):322-330.
11. Jaeck D, Bachellier P, Oussoultzoglou E, Eber JC, Wolf P. Surgical resection of hepatocellular carcinoma. Post-operative outcome and long-term results in Europe: an overview. Liver Transpl. 2004;10:S58-S63.
12. Kim SH, Kim DY, Lim JH, et al. Role of splenectomy in patients with hepatocellular carcinoma and hypersplenism. ANZ J Surg. 2013; 83(11):865-870.
13. Nomura Y, Kage M, Ogata T, et al. Influence of splenectomy in patients with liver cirrhosis and hypersplenism. Hepatol Res. Epub September 3, 2013.
14. Chen X P, Wu ZD, Huang ZY, Qiu FZ. Use of hepatectomy and sple-nectomy to treat hepatocellular carcinoma with cirrhotic hypersplenism. Br J Surg. 2005;92(3):334-339.
15. Lynch AM, Kapila R. Overwhelming postsplenectomy infection. Infect Dis Clin North Am. 1996;10(4):693-707.
16. Di Cataldo A, Puleo S, Li Destri G, et al. Splenic trauma and overwhelming postsplenectomy infection. Br J Surg. 1987;74(5):343-345.
17. Holdsworth RJ, Irving AD, Cuschieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg. 1991;78(9): 1031-1038.
18. Fuchs C, Scheer C, Schulz K, Dombrowski F, Brückmann S, Kuhn SO. Overwhelming postsplenectomy infection syndrome. Anaesthesist. 2014;63(3):225-230.
19. Atweh N, Kavic SM, Dudrick SJ. Portal vein thrombosis after splenectomy. J Am Coll Surg. 2001;192(4):551-552.
20. Lai W, Lu SC, Li GY, et al. Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularization. World J Gastroenterol. 2012;18(26):3443-3450.
21. Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut. 2005;54(5):691-697.
22. Pan C, Shi Y, Zhang JJ, et al. Single-center experience of 253 portal vein thrombosis patients undergoing liver transplantation in China. Transplant Proc. 2009;41(9):3761-3765.
23. Chaffanjon PC, Brichon PY, Ranchoup Y, Gressin R, Sotto JJ. Portal vein thrombosis following splenectomy for hematologic disease: prospective study with Doppler color fow imaging. World J Surg. 1998;22:1082-1086.
24. Marrero JA, Fontana RJ, Barrat A, et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology. 2005;41(4):707-716.
25. Gomaa AI, Hashim MS, Waked I. Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt. PLoS One. 6, 2014;9(3):e90929.
26. Koh WP, Robien K, Wang R, Govindarajan S, Yuan JM, Yu MC. Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study. Br J Cancer. 2011;105(9):1430-1435.
27. Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS. Alcohol, tobacco and obesity are synergistic risk factors for hepatocel-lular carcinoma. J Hepatol. 2005;42(2):218-224.
28. El-Zayadi AR. Heavy smoking and liver. World J Gastroenterol. 2006;12(38):6098-6101.
29. Ogata T, Okuda K, Sato T, et al. Long-term outcome of splenectomy in advanced cirrhotic patients with hepatocellular carcinoma and throm-bocytopenia. Kurume Med J. 2013;14;60(2):37-45.
30. Cao ZX, Chen X P, Wu ZD. Changes of immune function in patients with liver cirrhosis after splenectomy combined with resection of hepatocel-lular carcinoma. Hepatobiliary Pancreat Dis Int. 2003;2(4):562-565.
31. Wang Q, Sun K, Li XH, Peng BG, Liang LJ. Surgical treatment for hepatocellular carcinoma and secondary hypersplenism. Hepatobiliary Pancreat Dis Int. 2006;5(3):396-400.
32. Kim J, Kim CJ, Ko IG, Joo SH, Ahn HJ. Splenectomy affects the balance between hepatic growth factor and transforming growth factor-beta and its effect on liver regeneration is dependent on the amount of liver resection in rats. J Korean Surg Soc. 2012;82(4):238-245.
33. Ren YS, Qian NS, Tang Y, et al. Benefcial effects of splenectomy on liver regeneration in a rat model of massive hepatectomy. Hepatobiliary Pancreat Dis Int. 2012;11(1):60-65.